SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.52+3.4%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Abuckatatime who wrote (11300)8/17/1999 9:45:00 AM
From: aknahow  Read Replies (2) of 17367
 
Greg, apparently the combining of endpoints lowers the power of the trial, don't understand how or why, see earlier post. If true XOMA might have feared release of the numbers would lead to wrong calculations and a view either that approval was a slam dunk or that the drug had totally failed. So to avoid spooking the market the data was not released.

But this may not be true and indeed there may be good reasons why one does not release data when dealing with the FDA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News